clinical trial · NCT06500598

Compassionate Use of Evinacumab

$REGN →·—·approved for marketing

Pediatric Homozygous Familial Hypercholesterolemia (HoFH)Severe Hypertriglyceridemia (HTG)Dysbetalipoproteinemia (DBL)Evinacumab

brief summary

Provide compassionate use of evinacumab

started

—

primary completion

—

completion

—

last updated

Oct 28, 2025

detailed description

Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications. Availability will depend on location.

full record on clinicaltrials.gov ↗

sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol